PharmiWeb.com - Global Pharma News & Resources
19-Jun-2019

Anti-Infective Agents Market Size is Anticipated to Surpass USD 144.9 Bn up to 2026

Global Anti-Infective Agents Market Size is expected to reach USD 144.9 Billion by 2026 and growing CAGR around 3.6 % during the forecast period.

The global Anti-Infective Agents Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1281

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Anti-Infective Agents Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Anti-Infective Agents Market?
  • What is the market drivers, restrains, opportunities governing the global Anti-Infective Agents Market?
  • Which is the largest and the fastest growing segments in the global Anti-Infective Agents Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Anti-Infective Agents Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson amp; Johnson Services, Inc., Merck amp; Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1281

The Major Market Segments of GlobalAnti-Infective Agents Marketare as below:

Market Segmentation

Market Segmentation by Type:

  • Antibacterials
    • Cephalosporins
    • Penicillin
    • Fluoroquinolones
    • Macrolides
    • Carbapenem
    • Others
  • Antivirals
    • Azoles
    • Echinocandins
    • Polyenes
    • Others
  • Antifungals

Market Segmentation by Route of Administration:

  • Topical
  • Oral
  • IV
  • Others

Market Segmentation by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • E-Commerce
  • Others

Market Segmentation by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East amp; Africa

Regional Insights:

North America market was one of the main local markets regarding income in 2018. High pervasiveness of irresistible maladies incorporating clinic obtained contaminations in both, kids and grown-ups, and the resultant abuse of antibiotics combined with expanded availability of non-solution anti-infectives are the real drivers. The Asia Pacific is one of the quickest developing territorial market attributable to the nearness of high, neglected interest for novel medications, fast upgrades in medicinal services foundation combined with bringing issues to light among social insurance experts and patients.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Anti-Infective Agents
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Anti-Infective Agents Market By Type
1.2.2.1. Global Anti-Infective Agents Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Anti-Infective Agents Market Revenue Share By Type in 2017
1.2.2.3. Antibacterials
1.2.2.4. Antivirals
1.2.2.5. Antifungals
1.2.2.6. Others
1.2.3. Anti-Infective Agents Market By Route of Administration
1.2.3.1. Global Anti-Infective Agents Market Revenue and Growth Rate Comparison By Route of Administration (2015-2026)
1.2.3.2. Topical
1.2.3.3. Oral
1.2.3.4. IV
1.2.3.5. Others
1.2.4. Anti-Infective Agents Market By Distribution Channel
1.2.4.1. Global Anti-Infective Agents Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.4.2. Hospital Pharmacies
1.2.4.3. Retail Pharmacies
1.2.4.4. Specialty Pharmacies
1.2.4.5. E-Commerce
1.2.4.6. Others
1.2.5. Anti-Infective Agents Market by Geography
1.2.5.1. Global Anti-Infective Agents Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Anti-Infective Agents Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Anti-Infective Agents Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Anti-Infective Agents Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Anti-Infective Agents Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Anti-Infective Agents Major Manufacturers in 2017

CHAPTER 4. ANTI-INFECTIVE AGENTS MARKET BY TYPE

4.1. Global Anti-Infective Agents Revenue By Type
4.2. Antibacterials
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Antivirals
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Antifungals
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Other
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ANTI-INFECTIVE AGENTS MARKET BY ROUTE OF ADMINISTRATION

5.1. Global Anti-Infective Agents Revenue By Route of Administration
5.2. Topical
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Oral
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. IV
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ANTI-INFECTIVE AGENTS MARKET BY DISTRIBUTION CHANNEL

6.1. Global Anti-Infective Agents Revenue By Distribution Channel
6.2. Hospital Pharmacies
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Retail Pharmacies
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Specialty Pharmacies
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. E-Commerce
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Others
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA ANTI-INFECTIVE AGENTS MARKET BY COUNTRY

7.1. North America Anti-Infective Agents Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Anti-Infective Agents Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. Anti-Infective Agents Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE ANTI-INFECTIVE AGENTS MARKET BY COUNTRY

8.1. Europe Anti-Infective Agents Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Anti-Infective Agents Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC ANTI-INFECTIVE AGENTS MARKET BY COUNTRY

9.1. Asia-Pacific Anti-Infective Agents Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Anti-Infective Agents Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA ANTI-INFECTIVE AGENTS MARKET BY COUNTRY

10.1. Latin America Anti-Infective Agents Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Anti-Infective Agents Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST ANTI-INFECTIVE AGENTS MARKET BY COUNTRY

11.1. Middle East Anti-Infective Agents Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Anti-Infective Agents Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA ANTI-INFECTIVE AGENTS MARKET BY COUNTRY

12.1. Africa Anti-Infective Agents Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Anti-Infective Agents Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Abbott Laboratories
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Astellas Pharma Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Bayer AG
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bristol-Myers Squibb Company
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Gilead Sciences, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. GlaxoSmithKline plc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Johnson amp; Johnson Services, Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Merck amp; Co., Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Novartis AG
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Pfizer, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Sanofi
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1281

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 19-Jun-2019